Correction: Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia
A Correction onElevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia
Authors
- Chuyue Xiong
- Yingjuan Shen
- Xuzhe Duan (ORCID: https://orcid.org/0000-0001-8505-9789)
- Shida Pan
- Luo Yang (ORCID: https://orcid.org/0000-0003-0148-8987)
- Xiaomeng Liu (ORCID: https://orcid.org/0000-0002-3288-212X)
- Mengdie Jia
- Yi-Xiang Wang (ORCID: https://orcid.org/0000-0002-4021-4228)
- Yuxing Wang (ORCID: https://orcid.org/0000-0003-3079-5572)
- Junqing Luan
- Fusheng Wang
- Fanping Meng
- Jiahe Tian
- Yingying Yu
- Siyu Wang
Institutions
- King University (US)
- University of Science and Technology of China (CN)
- Peking University (CN)
- Chinese PLA General Hospital (CN)
- Chinese General Hospital College of Nursing and Liberal Arts (PH)
- Chinese People's Liberation Army (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-04-27
- DOI
- https://doi.org/10.3389/fimmu.2026.1857653
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00